RSS Amplifier

66.1 · Apr 12, 2025

Ozempic, Wegovy, Mounjaro: the latest insights on GLP-1s

0
Sign in to vote or save

Marcus Frick · 66.1

Read time: 10 minutes

Read online

Good morning, 66.1ers.
Welcome to issue #117 of 66.1.

Full access to this post and podcast is reserved for paid members of 66.1.

Free subscribers: if you want to hear my thoughts on:

  • The latest science about GLP-1 drugs and their effect on 175 different health markers

  • The risks and benefits of using a GLP-1 drug to lose weight

  • My take on using GLP-1s (and who might benefit from using them)

Get access to today’s post and all 117 issues of 66.1 by upgrading your subscription at the button below.

Paid Subscribers: thanks for your support. Your contribution allows us to continue developing 66.1 into your #1 longevity resource.

Today’s issue brought to you by Freedom Fats

Read the original on 6611.substack.com

Comments

Nothing yet. Say the first thing.

    Sign in to join the conversation.